Catalyst Pharmaceuticals, Inc. (CPRX)

CIK 0001369568 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q1-2026 —
FY-2025
Latest FY-2025 —
Q3-2025 —
Q2-2025 —
Q1-2025 —
FY-2024 —
Q3-2024 —
Q2-2024 —
Q1-2024 —
FY-2023 —
Q3-2023 —
Q2-2023 —
FY-2022

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover Page
Document and Entity Information
—
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Condensed Consolidated Statements of Operations and Comprehensive Income (loss)
—
Consolidated Statements of Operations and Comprehensive Income
Condensed Consolidated Statements of Operations and Comprehensive Income (loss) (P)
—
Consolidated Statements of Operations and Comprehensive Income (P)
Consolidated Statements of Changes In Stockholders' Equity
Consolidated Statements of Cash Flows
Notes
Accrued Expenses and Other Liabilities
Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income (loss)
Agreements
Basis of Presentation and Significant Accounting Policies
Benefit Plan
—
Collaborative and Licensing Arrangements
Commitments and Contingencies
Cybersecurity Risk Management, Strategy and Governance
—
Income Taxes
Insider Trading Arrangements
Inventory
Inventory, Net.
Investments
License and Acquired Intangibles, Net
Operating Leases
Organization and Description of Business
Pay Vs Performance Disclosure
Prepaid Expenses and Other Current Assets
Property and Equipment, Net
Stock Compensation
Stockholders' Equity
Subsequent Events